With the fastest ageing population in the world, Asia Pacific shows great potential for the sales of retail adult incontinence. While Japan has the oldest population and continues to contribute the largest percentage, developing countries like India and China are set to drive incontinence sales. With growing elderly population in two largest domestic markets of the world, rising income levels and spending appetites put these developing countries in good stead in driving up incontinence sales.
Adult Incontinence in Asia Pacific global briefing offers an insight into to the size and shape of the tissue and hygiene market, highlights buzz topics, emerging regions, countries and categories as well as pressing industry issues and white spaces. It identifies the opportunity zones within tissue and hygiene, analyses leading companies and brands, assesses the importance of private label and offers strategic analysis of major factors influencing the market - be they new product developments, economic/lifestyle/environmental influences, distribution or pricing issues. Forecasts illustrate how the market is set to change and criteria for success.
Product coverage: Away-from-Home Tissue and Hygiene, Retail Tissue and Hygiene, Rx/Reimbursement adult incontinence, Total Tissue and Hygiene.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Tissue and Hygiene market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Our reports have been used by over 10K customers, including:
80 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see higher current value growth in 2020 than was seen the previous year. One of the factors driving growth in this year is COVID-19. As news about the virus emerged and the country went into lockdown, consumers began panic-buying in March, stockpiling certain consumer health products, such as analgesics, cough,...
101 pages •
By Euromonitor International
• Nov 2020
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
215 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
42 pages •
By Euromonitor International
• Jan 2021
2020 accelerated the long overdue shift of the industry to e-commerce. It also saw direct sellers embrace digital selling and store-based retailers experiment with different strategies to keep consumers coming back for more. As global consumers put the first year of the pandemic behind them, there are some permanent shifts in consumer behaviour...
111 pages •
By Euromonitor International
• Jan 2021
The emergence of the pandemic in Colombia and subsequent lockdown by the government in an attempt to control the spread of the virus resulted in rising unemployment and decreasing disposable incomes, and led to many local consumers prioritising their spending on essential purchases, including groceries and medicines. Consumer health therefore,...
116 pages •
By Euromonitor International
• Jan 2021
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
119 pages •
By Euromonitor International
• Jan 2021
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
111 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see lower current value growth in 2020 than was seen the previous year, largely as a result of COVID-19. The hardest hit categories in 2020 are likely to be sports nutrition and weight management. The demand for these products was significantly dampened due to the introduction of lockdown restrictions, which...
90 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see slightly higher current value growth in 2020 than was seen in 2019, with COVID-19 expected to be one of the main factors dictating growth in Uruguay. While the COVID-19 outbreak in Uruguay had little impact in terms of infections and deaths due to the country’s good healthcare system, locals’ concern about...
96 pages •
By Euromonitor International
• Nov 2020
COVID-19 is expected to have a varied effect on the different categories of consumer health in 2020. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, vitamins and dietary supplements are expected to perform well in 2020 as the products in these categories are popular remedies for the main symptoms of COVID-19 or...
OTC
Dietary Supplement
Healthcare
Kazakhstan
Birth Rate
Analgesic Medicine Sales
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.